MiR-29a-Mediated CD133 Expression Contributes to Cisplatin Resistance in CD133(+) Glioblastoma Stem Cells

Yang, L; Li, N; Yan, ZJ; Li, C; Zhao, ZM

Zhao, ZM (reprint author), Hebei Med Univ, Dept Neurosurg, Hosp 2, Shijiazhuang 050000, Hebei, Peoples R China.

JOURNAL OF MOLECULAR NEUROSCIENCE, 2018; 66 (3): 369

Abstract

CD133 positive (CD133(+)) cells are cancer stem cells in glioblastoma that are associated with poor prognosis and resistance to radiotherapy. However,......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索